GrantPostedDiscretionary

Advancing Research on Molecular Targets and Mechanisms that Influence the Interplay Between Sex Hormones, HIV, and Addictive Substances (R21 Clinical Trials Not Allowed)

National Institutes of Health
RFA-DA-26-008
Application Deadline
Mar 13, 2025
Closed
Days Remaining
0
Deadline passed
Award Ceiling
Total Program Funding

Grant Opportunity Analysis

The National Institutes of Health (NIH) has announced a funding opportunity titled "Advancing Research on Molecular Targets and Mechanisms that Influence the Interplay Between Sex Hormones, HIV, and Addictive Substances," aimed at enhancing understanding of how sex hormones affect comorbid HIV and substance use disorders (SUDs). This initiative seeks to support studies that delineate the biological mechanisms influenced by sex hormones, with the goal of identifying potential therapeutic targets for addressing HIV-SUD comorbidity. The total funding available for this opportunity is $3 million, with individual project budgets capped at $275,000 over a two-year period. Interested applicants must submit their proposals electronically by March 13, 2025, and are required to include a Plan for Enhancing Diverse Perspectives (PEDP) as part of their application. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.

Eligible Applicants

Others
Additional Eligibility Information

Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

Grant Documents

1 Files
RFA-DA-26-008.html
HTML109 KB8/24/2024
AI Summary
The Department of Health and Human Services, through the National Institutes of Health (NIH), has announced a funding opportunity aimed at advancing research on the interplay between sex hormones, HIV, and addictive substances via the R21 Exploratory/Developmental Research Grant (Funding Opportunity Number: RFA-DA-26-008). The primary purpose of this funding opportunity is to enhance understanding of how sex hormones affect the outcomes of comorbid HIV and substance use disorders (SUDs), and to identify biological mechanisms that may serve as therapeutic targets. Eligible applicants include higher education institutions, nonprofit organizations, and for-profit entities, amongst others. The total funding available is $3 million, with individual project budgets capped at $275,000 over two years. Applications are to be submitted electronically, and adherence to specific application guidelines, including a Plan for Enhancing Diverse Perspectives (PEDP), is mandatory. The application process involves detailed reviews emphasizing innovation, significance, feasibility, and the expertise of investigators. The opportunity underscores NIH’s commitment to understanding health disparities related to sex differences in HIV and addiction, aiming to provide effective interventions for affected populations.

Related Grant Opportunities

Project Timeline

postedOriginal Opportunity PostedAug 15, 2024
deadlineApplication DeadlineMar 13, 2025
expiryArchive DateApr 18, 2025

Funding Details

No cost sharing required

Agency & Classification

Agency
National Institutes of Health(HHS-NIH11)
Funding Category
Health
Funding Instrument
Grant

Grantor Contact

CFDA Numbers

93.279

Official Sources